Pint Pharma GmbH Sustainability Profile
Pint Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Austria (AT) and operates extensively across Europe. Founded in 2008, the company has established itself as a leader in the development and distribution of innovative medicines, particularly in the fields of oncology and rare diseases. Pint Pharma is renowned for its commitment to providing high-quality, patient-centric solutions, with a portfolio that includes both proprietary products and strategic partnerships. Their unique approach to drug development and market access has positioned them favourably within the competitive landscape. With a focus on enhancing patient outcomes, Pint Pharma continues to achieve significant milestones, solidifying its reputation as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Pint Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pint Pharma GmbH's score of 26 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pint Pharma GmbH's reported carbon emissions
Pint Pharma GmbH, headquartered in Austria (AT), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Pint Pharma GmbH's climate commitments and emissions data may be influenced by its corporate family relationships. However, no specific initiatives or targets have been cascaded from a parent organization or related entities. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. While Pint Pharma GmbH has yet to establish or disclose its own climate commitments, the industry trend suggests a growing emphasis on environmental responsibility and emissions management.
How Carbon Intensive is Pint Pharma GmbH's Industry?
How Carbon Intensive is Pint Pharma GmbH's Location?
Pint Pharma GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pint Pharma GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
